Miller Fisher syndrome (MFS): clinical features
Evidence-based neurology checklist on miller fisher syndrome (mfs): clinical features: Demographic features Males are affected twice as often as females The mean onset age is about 40 years It is often seasonal: it is more prevalent in the spring Anti GQ1b antibodies are present in about 90% of…
Demographic features
- Males are affected twice as often as females
- The mean onset age is about 40 years
- It is often seasonal: it is more prevalent in the spring
- Anti GQ1b antibodies are present in about 90% of cases
Triggers
Central features
Peripheral features
Variants
Outcome
References
- Mori M, Kuwabara S, Fukutake T, Yuki N, Hattori T. Clinical features and prognosis of Miller Fisher syndrome. Neurology 2001; 56:1104-1106.
- Aranyi Z, Kovacs T, Sipos I, Bereczki D. Miller Fisher syndrome: brief overview and update with a focus on electrophysiological findings. Eur J Neurol 2012; 19:15-20.
- Mori M, Kuwabara S. Fisher syndrome. Curr Treat Options Neurol 2011; 13:71-78.
- Ratnarajan G, Thompson A, Dodridge C, Parry A, Elston J. Novel variant of Miller Fisher syndrome occurring with tumor necrosis factor α antagonist therapy. JAMA Neurol 2015; 72:1377-1378.
- Shin IS, Baer AN, Kwon HJ, Papadopoulos EJ, Siegel JN. Guillain-Barré and Miller Fisher syndromes occurring with tumor necrosis factor alpha antagonist therapy. Arthritis Rheum 2006; 54:1429-1434.
- And 8 more. Subscribe to see the full list
